Clinical Research

parexel-opens-its-6th-office-in-china-located-in-shenyang

Parexel opens its 6th office in China

  • China
  • |
  • News

Singapore: Parexel International opened a new office in Shenyang, China. This location will support growing client demand for a broad range of clinical development capabilities in the country and throughout the Asia Pacific region. The... Read more

merck-serono-quintiles-sign-clinical-research-deal

Merck Serono, Quintiles sign clinical research deal...


  • US
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: Merck Serono and Quintiles have signed a new, five-year clinical development agreement. This strategic collaboration... Read more

kansas-bioscience-authority-kba-pays-received-usd400-000-to-pra-create-80-new-jobs

US state pays PRA $0.4 mn for creating jobs


  • US
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: PRA, a leading clinical research organization, has received a $400,000 grant from the Kansas Bioscience Authority... Read more

research-collaboration

Johns Hopkins to collaborate with Chinese university

  • China
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: The training of next-generation clinical investigators in China is at the core of a new collaboration between Sun Yat-sen University... Read more

dr-douglas-francis-clinical-network-services-new-senior-regulatory-toxicologist-for-biodesk-product-development-planning-and-regulatory-affairs-service

CNS hires former TGA toxicologist for BioDesk

  • Australia
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: Clinical Network Services (CNS), an Australian-based CRO offering integrated development services, has appointed former Therapeutic... Read more

mr-garth-tierney-the-new-executive-vice-president-asia-pacific-inc-research

Garth Tierney is executive VP of INC CRO

  • Australia
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: INC Research has promoted Mr Garth Tierney to executive vice president, Asia Pacific. He will be responsible for driving the... Read more

oecd-recommends-member-eu-governments-to-harmonize-their-clinical-trial-approval-processes

OECD: EU should harmonize trial regulations

  • Europe
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: Increasingly complex and inconsistent clinical trial regulations are causing delays, raising costs and leading to a decline in... Read more

cogstate-is-betting-big-on-its-soon-to-be-launched-cognitive-test-cognigram

Cogstate bets big on its cognitive test Cognigram

  • Company Results
  • |
  • By BioSpectrum Bureau
  • |
  • 1 Comment

Singapore: Australian company Cogstate has earned overall revenue of $6.14 million and a net loss of $0.49 million in the half year ending... Read more

dr-gautam-daftary-managing-director-bharat-serums-and-vaccines-india

Dr Gautam Daftary: The Indian biologics pioneer

  • India
  • |
  • Influencers
  • |
  • By Manasi Vaidya
  • |
  • 0 Comment

Indian company Bharat Serums and Vaccines boasts of a product portfolio that includes many firsts in India and the world and has carved... Read more

clinical-trial

OxOnc, Pfizer drug trial to be held in Asia

  • Taiwan
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: OxOnc Development, an oncology development company founded by pharmaceutical development executives and oncology experts, has... Read more

draft-guidance

FDA offers guidance on Alzheimer’s drug development

  • US
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: The US Food and Drug Administration has issued a proposal designed to assist companies developing new treatments for patients... Read more

china-market-solasia-pharma

Solasia appoints Yoshihiro Arai as president

  • China
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: Mr Yoshihiro Arai, currently general manager and head of development of Solasia Pharma, has been promoted to president and representative... Read more

Special Features

Survey Box

Ranbaxy Controversy

Will the Ranbaxy controversy end the Indian pharma dominion in the US market?

Send this article by email

X